Form 4: Elanco Animal Health Director William F. Doyle Acquires 15,000 Shares

Director William F. Doyle purchased 15,000 shares of Elanco Animal Health Inc. on March 8, 2024, at a price of $16.3 per share.

Summary

• On March 8, 2024, William F. Doyle, a director of Elanco Animal Health Inc., acquired 15,000 shares of the company's common stock.
• The purchase price was $16.3 per share.
• Following the transaction, Doyle directly owns 61,330 shares of Elanco Animal Health Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. An insider purchase can be interpreted as a sign of confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This transaction is a routine disclosure of insider trading activity. It is common for directors and officers of publicly traded companies to buy and sell shares of their company's stock. These transactions are closely monitored by regulators and investors for insights into management's view of the company's prospects.

Stakeholder Impact

• The purchase could have a minor positive impact on shareholder sentiment.

Key Dates